Which hedge funds own TXMD? THERAPEUTICSMD INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in TXMD (THERAPEUTICSMD INC) in their Q2 2026 13F filings, worth $5.7m in total. The largest holder by portfolio weight is Tejara Capital LTD at 0.3% of its book. 2 exited: Cygnus Capital Advisors, LLC, Squadron Capital Management LLC.
Who discovered TXMD first?
Earliest meaningful positions among the 3 tracked managers we observed opening TXMD since Q2 2013.
1 RA Capital Management, L.P. First reported Q2 2013 High conviction 5.5%initial weight · $34.1m Exitedby Q3 2021 · held 13q –stock change
Weight of RA Capital Management, L.P.'s 13F book in TXMD, by quarter
- 9.4% peak weight, Q4 2013
- $62.1m peak reported value
- 13 quarters held, in 2 separate spells
- 8q before the median tracked entry
2 Rubric Capital Management LP First reported Q4 2018 · ≥1% from Q1 2019 0.7%initial weight · $5.9m 0.02%still holding · 31q -13%stock since Q4 2018
Weight of Rubric Capital Management LP's 13F book in TXMD, by quarter
- 3.1% peak weight, Q4 2019
- $26.7m peak reported value
- 31 quarters held
The stock's split-adjusted price moved -13% from Q4 2018 to Q2 2026.
6 managers already held TXMD when our coverage of them began
Tejara Capital LTD (Q1 2026), Clearline Capital LP (Q1 2026), Adar1 Capital Management, LLC (Q1 2026), Citadel Advisors LLC (Q1 2026), Cygnus Capital Advisors, LLC (Q1 2026), Squadron Capital Management LLC (Q1 2026).
Their first filing on record already includes TXMD, so when they first bought it is unknown. They are not ranked above.
View discovery timeline
Dots mark the ranked managers' first reported quarters. Price is the quarter-end price implied by 13F filings, split-adjusted, shown from Q4 2018 where the series is continuous. Coverage widened in Q1 2026 from about a hundred managers to over a thousand, so holders and new holders are shown relative to the managers filing each quarter.
How this is calculated
13F filings are quarterly snapshots of long US-listed equity positions. They do not show exact purchase dates, intra-quarter trading, short positions, most derivatives, or a manager's actual performance. "First reported" is the first quarter-end filing that shows the position.
A manager is ranked only if we observed it filing, without TXMD, within two quarters before its first position. Ranking is by the first quarter the position reached 1% of the manager's 13F book in a run of at least 2 filings, then by peak weight. "High conviction" means a peak weight of at least 5%.
Stock changes are the split-adjusted change in the quarter-end price implied by 13F filings, excluding dividends. They describe the stock over the period, not the return any manager earned. Phases are cut where the share of tracked managers holding TXMD passed one third and two thirds of its peak.
Which hedge funds hold TXMD? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Tejara Capital LTD | Q2 2026 | 0.3% | $761.3k | 344,482 | -0% | held |
| Clearline Capital LP | Q2 2026 | 0.1% | $1.4m | 635,222 | 0% | held |
| Adar1 Capital Management, LLC | Q2 2026 | 0.0% | $756.8k | 342,447 | 64% | added |
| Rubric Capital Management LP | Q2 2026 | 0.0% | $2.6m | 1,192,191 | 0% | held |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $190.3k | 86,095 | 26% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Cygnus Capital Advisors, LLC | 0.1% | $18.0k |
| Squadron Capital Management LLC | 1.2% | $849.2k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of TXMD changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $6.1m |
| Q1 2026 | 8 | $6.1m |
| Q4 2025 | 2 | $2.1m |
| Q3 2025 | 2 | $1.3m |
| Q2 2025 | 2 | $1.4m |
| Q1 2025 | 2 | $1.1m |
| Q4 2024 | 2 | $1.0m |
| Q3 2024 | 1 | $2.0m |
| Q2 2024 | 1 | $1.9m |
| Q1 2024 | 2 | $2.8m |
| Q4 2023 | 1 | $2.7m |
| Q3 2023 | 1 | $3.6m |
| Q2 2023 | 1 | $4.9m |
| Q1 2023 | 1 | $4.5m |
| Q4 2022 | 1 | $9.8m |
| Q3 2022 | 1 | $7.7m |
Counts every tracked manager that disclosed TXMD in that quarter's filing, including managers that have since stopped filing.